Rheumatoid Arthritis & Chemotherapy: Understanding Treatment Approaches

Rheumatoid arthritis (RA) is an autoimmune disorder causing chronic joint inflammation and damage. Chemotherapy is not a standard treatment for RA; it is primarily used for cancer. Instead, RA management focuses on reducing inflammation, preventing joint damage, and relieving pain through several medication classes:

• Disease-Modifying Antirheumatic Drugs (DMARDs): First-line therapy that slows disease progression. Examples include methotrexate, leflunomide, and sulfasalazine.
• Biologic Therapies: Injectable medications targeting specific immune pathways (e.g., adalimumab, infliximab, etanercept, rituximab).
• Targeted Synthetic DMARDs: Newer oral agents like tofacitinib and baricitinib that block specific inflammatory signals.
• NSAIDs: Ibuprofen, naproxen, and others reduce pain, inflammation, and stiffness.
• Corticosteroids: Short-term, low-dose prednisone can quickly control flares but carries long-term side effects.

Rheumatologists tailor treatment based on disease severity, patient response, and the balance of efficacy versus side effects. Regular monitoring ensures optimal management.